Taipa, Macao

Yingqiong Xu

This inventor holds 1 USPTO granted patent. Top assignee: Macau University of Science and Technology. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yingqiong Xu. Retrieved from https://idiyas.com/inventor/yingqiong-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yingqiong Xu in Sphingolipid Research

Introduction

Yingqiong Xu is a notable inventor based in Taipa, MO. He has made significant contributions to the field of biochemistry, particularly in the isolation and application of sphingolipids. His work has implications for treating inflammatory diseases, showcasing the potential of these compounds in medical science.

Latest Patents

Yingqiong Xu holds a patent titled "Method of isolating sphingolipids from cordyceps and their use." This innovative method allows for the isolation of various sphingolipid portions, including sphingoid bases, ceramides, glycosphingolipids, and phosphosphingolipids. The isolated sphingolipid portions contain significant amounts of previously unreported sphingolipids, which exhibit exceptional immunosuppressive activities. His research also outlines methods for treating subjects suffering from inflammatory diseases, such as autoimmune or allergic conditions, by administering these isolated sphingolipids.

Career Highlights

Yingqiong Xu is affiliated with the Macau University of Science and Technology, where he continues to advance his research in sphingolipid applications. His work has garnered attention for its potential therapeutic benefits, particularly in the realm of immunology.

Collaborations

Yingqiong Xu has collaborated with notable colleagues, including Jia-Ning Mi and Yuwei Han. Their joint efforts contribute to the ongoing research and development in the field of sphingolipids.

Conclusion

Yingqiong Xu's innovative research in sphingolipid isolation and application represents a significant advancement in biochemistry and medicine. His contributions may pave the way for new treatments for inflammatory diseases, highlighting the importance of continued research in this area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…